Khalaji Amirreza, Riahi Farshad, Rafieezadeh Diana, Khademi Fahimeh, Fesharaki Shahin, Joni Saeid Sadeghi
Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University Atlanta, GA, USA.
Department of Radiology, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Int J Physiol Pathophysiol Pharmacol. 2025 Apr 25;17(2):45-51. doi: 10.62347/YHID9574. eCollection 2025.
Lung cancer remains a leading cause of cancer-related mortality worldwide, and early detection is essential for improving patient outcomes. This study evaluates the role of artificial intelligence (AI) in lung nodule detection, focusing on its potential to enhance the accuracy of early lung cancer diagnosis. We assess the performance of AI tools, particularly convolutional neural networks (CNNs), in identifying and segmenting lung nodules from computed tomography (CT) and X-ray images. Our findings indicate that AI systems achieve a sensitivity of 70-90%, comparable to that of experienced radiologists, while reducing false-positive rates. In pulmonary nodule detection on CT scans, AI demonstrated over 95% sensitivity with fewer than one false-positive per scan. The implementation of AI as a "second reader" significantly improved detection accuracy. Despite these advancements, challenges remain, including high false-positive rates, issues with generalizability across diverse populations, regulatory concerns, and skepticism among healthcare professionals. This study highlights the promise of AI in supporting radiologists and improving lung cancer screening while emphasizing the need for further research to enhance specificity and address existing limitations.
肺癌仍然是全球癌症相关死亡的主要原因,早期检测对于改善患者预后至关重要。本研究评估了人工智能(AI)在肺结节检测中的作用,重点关注其提高早期肺癌诊断准确性的潜力。我们评估了人工智能工具,特别是卷积神经网络(CNN),从计算机断层扫描(CT)和X射线图像中识别和分割肺结节的性能。我们的研究结果表明,人工智能系统的灵敏度达到70-90%,与经验丰富的放射科医生相当,同时降低了假阳性率。在CT扫描的肺结节检测中,人工智能的灵敏度超过95%,每次扫描的假阳性少于1个。将人工智能作为“第二阅片者”的应用显著提高了检测准确性。尽管取得了这些进展,但挑战仍然存在,包括高假阳性率、不同人群的通用性问题、监管问题以及医疗保健专业人员的怀疑态度。本研究强调了人工智能在支持放射科医生和改善肺癌筛查方面的前景,同时强调需要进一步研究以提高特异性并解决现有局限性。